Meibum supplies the tear film’s outer lipid layer, which limits water evaporation from the ocular surface. With fewer functioning glands, this protective contribution can weaken, making the tear film less stable and allowing irritation associated with evaporative dry eye to develop. This mechanism links gland integrity to maintenance of a continuously protective tear-film surface.
Structural dropout refers to reduced or absent gland tissue, whereas functional decline concerns how well the remaining glands produce or release meibum. These dimensions can therefore provide different information: morphology may show loss of gland architecture, while clinical assessment helps determine its effect on secretion and tear-film performance. Considering both supports a more complete evaluation.
The measurement adds an anatomical perspective to symptoms and tear-film findings. Clinicians can use gland morphology to support diagnostic assessment, while researchers can examine how gland changes relate to disease mechanisms and possible risk factors. This makes gland-loss evaluation useful not only for recognizing ocular-surface disease, but also for studying why tear-film function deteriorates.
Meibography is used to assess meibomian gland morphology, including the extent of structural reduction or disappearance. Its findings can support diagnosis when interpreted alongside related eye examinations. Repeated assessments also provide a way to monitor whether gland changes remain stable or progress over time, making the technique relevant to both clinical evaluation and longitudinal research.
Meibography focuses on gland structure, whereas related eye examinations place those findings in the context of ocular-surface irritation and tear-film performance. Together, they can support clinical diagnosis and help clinicians judge the relevance of visible gland changes. Using both types of information also strengthens monitoring of disease progression and changes in tear-film function.
Researchers can use measurements of gland loss to investigate disease mechanisms, examine potential risk factors, and evaluate approaches intended to preserve or restore tear-film function. Structural measurements provide an outcome that can be followed alongside ocular-surface status. This helps connect changes in gland morphology with whether an intervention may protect the tear film or improve its stability.